Literature DB >> 9848222

Fate of orthotopic corneal allografts in C57BL/6 mice.

J Yamada1, J W Streilein.   

Abstract

Our aim was to determine whether corneal allografts placed in normal eyes of C57BL/6 mice enjoy immune privilege, and whether recipients of long-standing grafts acquire donor-specific ACAID. C57BL/6 mice received corneal grafts from BALB/c, C57BL/6, C3H, B10.D2 or BALB.B mice; for comparison, BALB/c mice received C3H or C57BL/6 corneal allografts. Delayed hypersensitivity and anterior chamber associated immune deviation (ACAID) induction were assessed in recipient mice at four and eight weeks after grafting. It was found that C57BL/6 mice resemble BALB/c mice in mounting more vigorous rejection reactions against minor H, rather than MHC, alloantigenic corneas, and in the acquisition of donor-specific DH within four weeks of engraftment. In addition, C57BL/6 mice with long-standing, healthy allografts display donor-specific ACAID. However, C57BL/6 mice differ from BALB/c mice in that (1) fewer allodisparate corneal grafts were accepted indefinitely; and (2) rejection in these eyes correlated with sustained donor-specific DH. It was concluded that immune privilege is less secure in the eyes of C57BL/6 mice, compared to BALB/c mice. This conclusion is discussed in terms of known polymorphic differences between these mouse strains at genetic loci governing (a) immune responsiveness, (b) alloform of Fas ligand, and (c) bias of immune response toward Th1 or Th2 phenotypes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9848222     DOI: 10.1016/s0966-3274(98)80041-5

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  10 in total

1.  Evaluation of corneal graft rejection in a mouse model.

Authors:  J Plsková; L Kuffová; V Holán; M Filipec; J V Forrester
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

Review 2.  Animal models of high-risk corneal transplantation: A comprehensive review.

Authors:  Rohan Bir Singh; Anna Marmalidou; Afsaneh Amouzegar; Yihe Chen; Reza Dana
Journal:  Exp Eye Res       Date:  2020-07-25       Impact factor: 3.467

Review 3.  Therapeutic approaches for induction of tolerance and immune quiescence in corneal allotransplantation.

Authors:  Maryam Tahvildari; Afsaneh Amouzegar; William Foulsham; Reza Dana
Journal:  Cell Mol Life Sci       Date:  2018-01-06       Impact factor: 9.261

4.  Deletion of the chemokine receptor CCR1 prolongs corneal allograft survival.

Authors:  Pedram Hamrah; Satoru Yamagami; Ying Liu; Qiang Zhang; Sudhir S Vora; Bao Lu; Craig J Gerard; M Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-03       Impact factor: 4.799

5.  Feasibility study of lamellar keratoplasty in a murine model.

Authors:  Ting Huang; Stephen R Planck; James T Rosenbaum; Ellen J Lee
Journal:  Ocul Immunol Inflamm       Date:  2009 Jul-Aug       Impact factor: 3.070

6.  Lymphangiogenesis and angiogenesis: concurrence and/or dependence? Studies in inbred mouse strains.

Authors:  Shintaro Nakao; Kazuichi Maruyama; Souska Zandi; Mark I Melhorn; Mahdi Taher; Kousuke Noda; Eyad Nusayr; Tom Doetschman; Ali Hafezi-Moghadam
Journal:  FASEB J       Date:  2009-10-26       Impact factor: 5.191

Review 7.  Maintaining T cell tolerance of alloantigens: Lessons from animal studies.

Authors:  Kortney A Robinson; William Orent; Joren C Madsen; Gilles Benichou
Journal:  Am J Transplant       Date:  2018-08       Impact factor: 8.086

8.  Neutralization of mouse interleukin-17 bioactivity inhibits corneal allograft rejection.

Authors:  XueDong Chen; ShiYong Zhao; XianLing Tang; HongYan Ge; Ping Liu
Journal:  Mol Vis       Date:  2011-08-11       Impact factor: 2.367

9.  The atypical chemokine receptor-2 does not alter corneal graft survival but regulates early stage of corneal graft-induced lymphangiogenesis.

Authors:  Tian Yu; J V Forrester; Gerard J Graham; Lucia Kuffova
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-07-27       Impact factor: 3.117

10.  Topical VEGF-C/D Inhibition Prevents Lymphatic Vessel Ingrowth into Cornea but Does Not Improve Corneal Graft Survival.

Authors:  Ann-Charlott Salabarria; Manuel Koch; Alfrun Schönberg; Elisabeth Zinser; Deniz Hos; Matthias Hamdorf; Thomas Imhof; Gabriele Braun; Claus Cursiefen; Felix Bock
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.